Your browser doesn't support javascript.
COVID-19 Vaccine Effectiveness during a Prison Outbreak when Omicron was the Dominant Circulating Variant-Zambia, December 2021.
Simwanza, John; Hines, Jonas Z; Sinyange, Danny; Sinyange, Nyambe; Mulenga, Chilufya; Hanyinza, Sarah; Sakubita, Patrick; Langa, Nelia; Nowa, Haggai; Gardner, Priscilla; Saasa, Ngonda; Chitempa, Graham; Simpungwe, James; Malambo, Warren; Hamainza, Busiku; Chipimo, Peter J; Kapata, Nathan; Kapina, Muzala; Musonda, Kunda; Liwewe, Mazyanga; Mwale, Consity; Fwoloshi, Sombo; Mulenga, Lloyd B; Agolory, Simon; Mukonka, Victor; Chilengi, Roma.
  • Simwanza J; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
  • Hines JZ; National Malaria Elimination Centre, Lusaka, Zambia.
  • Sinyange D; Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Sinyange N; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
  • Mulenga C; National Malaria Elimination Centre, Lusaka, Zambia.
  • Hanyinza S; Zambia National Public Health Institute, Lusaka, Zambia.
  • Sakubita P; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
  • Langa N; Zambia National Public Health Institute, Lusaka, Zambia.
  • Nowa H; Zambia National Public Health Institute, Lusaka, Zambia.
  • Gardner P; Zambia National Public Health Institute, Lusaka, Zambia.
  • Saasa N; Zambia National Public Health Institute, Lusaka, Zambia.
  • Chitempa G; Zambia Correctional Services, Lusaka, Zambia.
  • Simpungwe J; Lusaka Province Health Office, Lusaka, Zambia.
  • Malambo W; University of Zambia, School of Veterinary Medicine, Department of Disease Control, Lusaka, Zambia.
  • Hamainza B; Lusaka District Health Office, Lusaka, Zambia.
  • Chipimo PJ; Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Kapata N; Centers for Disease Control and Prevention, Lusaka, Zambia.
  • Kapina M; National Malaria Elimination Centre, Lusaka, Zambia.
  • Musonda K; Zambia National Public Health Institute, Lusaka, Zambia.
  • Liwewe M; Zambia National Public Health Institute, Lusaka, Zambia.
  • Mwale C; Zambia National Public Health Institute, Lusaka, Zambia.
  • Fwoloshi S; Zambia National Public Health Institute, Lusaka, Zambia.
  • Mulenga LB; Zambia National Public Health Institute, Lusaka, Zambia.
  • Agolory S; Lusaka Province Health Office, Lusaka, Zambia.
  • Mukonka V; Ministry of Health, Lusaka, Zambia.
  • Chilengi R; Ministry of Health, Lusaka, Zambia.
Am J Trop Med Hyg ; 107(5): 1055-1059, 2022 Nov 14.
Article in English | MEDLINE | ID: covidwho-2024901
ABSTRACT
During a COVID-19 outbreak in a prison in Zambia from December 14 to 19, 2021, a case-control study was done to measure vaccine effectiveness (VE) against infection and symptomatic infection, when the Omicron variant was the dominant circulating variant. Among 382 participants, 74.1% were fully vaccinated, and the median time since full vaccination was 54 days. There were no hospitalizations or deaths. COVID-19 VE against any SARS-CoV-2 infection was 64.8%, and VE against symptomatic SARS-CoV-2 infection was 72.9%. COVID-19 vaccination helped protect incarcerated persons against SARS-CoV-2 infection during an outbreak while Omicron was the dominant variant in Zambia. These findings provide important local evidence that might be used to increase COVID-19 vaccination in Zambia and other countries in Africa.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Am J Trop Med Hyg Year: 2022 Document Type: Article Affiliation country: Ajtmh.22-0368

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Am J Trop Med Hyg Year: 2022 Document Type: Article Affiliation country: Ajtmh.22-0368